Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Lara A. Danziger-Isakov, MD, MPH

Professor
Cincinnati Children's Hospital
Cincinnati, OH, United States

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is the Director of the Immunocompromised Host Infectious Disases Service and Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at St. Louis Children's Hospital. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on solid organ and stem cell transplantation. In addition, Dr. Danziger-Isakov focuses on clinical trials to evaluate vaccine responses in immunocompomised hosts including live viral vaccination after solid organ transplantation. She additionally focuses on newe therapies and new detection methods for infectious diseases in pediatric patients.

Disclosure(s): AiCuris.: Grant/Research Support; Ansun BioPharma: Grant/Research Support; Astellas Pharma Global Development, Inc: Advisor/Consultant, Grant/Research Support; kamada: Advisor/Consultant; Merck Sharp & Dohme Corporation: Grant/Research Support; Pfizer (Any division): Grant/Research Support; Takeda Pharmaceuticals: Grant/Research Support

Presentation(s):